Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors

O Zamani; B Combe; H-P Tony; J S Burson; H Tahir; M Østergaard; B Augendre-Ferrant; A Beselin; E Larsson; M Casillas; J Smolen

doi:10.1080/03009742.2016.1207299

Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors

O Zamani, B Combe, H-P Tony, J S Burson, H Tahir, M Østergaard, B Augendre-Ferrant, A Beselin, E Larsson, M Casillas, J Smolen

Department of Clinical Medicine

Original language	English
Article number	PP21
Journal	Scandinavian Journal of Rheumatology
Volume	45
Issue number	sup128
Number of pages	2
ISSN	0300-9742
DOIs	https://doi.org/10.1080/03009742.2016.1207299
Publication status	Published - 2016

Access to Document

10.1080/03009742.2016.1207299

Cite this

Zamani, O., Combe, B., Tony, H-P., Burson, J. S., Tahir, H., Østergaard, M., Augendre-Ferrant, B., Beselin, A., Larsson, E., Casillas, M., & Smolen, J. (2016). Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors. Scandinavian Journal of Rheumatology, 45(sup128), [PP21]. https://doi.org/10.1080/03009742.2016.1207299

Zamani, O, Combe, B, Tony, H-P, Burson, JS, Tahir, H, Østergaard, M, Augendre-Ferrant, B, Beselin, A, Larsson, E, Casillas, M & Smolen, J 2016, 'Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors', Scandinavian Journal of Rheumatology, vol. 45, no. sup128, PP21. https://doi.org/10.1080/03009742.2016.1207299

@article{1c8a1d086edd4f0d9f568fd1454f4e20,

title = "Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors",

author = "O Zamani and B Combe and H-P Tony and Burson, {J S} and H Tahir and M {\O}stergaard and B Augendre-Ferrant and A Beselin and E Larsson and M Casillas and J Smolen",

year = "2016",

doi = "10.1080/03009742.2016.1207299",

language = "English",

volume = "45",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "sup128",

}

TY - ABST

T1 - Efficacy and safety of baricitinib in patients with active rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors

AU - Zamani, O

AU - Combe, B

AU - Tony, H-P

AU - Burson, J S

AU - Tahir, H

AU - Østergaard, M

AU - Augendre-Ferrant, B

AU - Beselin, A

AU - Larsson, E

AU - Casillas, M

AU - Smolen, J

PY - 2016

Y1 - 2016

U2 - 10.1080/03009742.2016.1207299

DO - 10.1080/03009742.2016.1207299

M3 - Conference abstract in journal

C2 - 27687481

SN - 0300-9742

VL - 45

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - sup128

M1 - PP21

ER -